Three Case Reports of Hand-Foot Syndrome with Gefitinib

By Razis Evangelia   Karina Maria   Karanastassi Sofia   Fountzilas George  

Cancer Investigation, Vol. 24, Iss. 5, 2006-06 ,pp. : 514-516

Informa Healthcare

Access to resources Recommend Favorite

Impact of prophylactic pyridoxine on occurrence of hand–foot syndrome in patients receiving capecitabine for advanced or metastatic breast cancer

By Yoshimoto Nobuyasu  

Breast Cancer, Vol. 17, Iss. 4, 2010-10 ,pp. : 298-302

Springer Publishing Company

Access to resources Recommend Favorite

Hand-foot Syndrome Induced by High-dose, Short-term, Continuous 5-Fluorouracil Infusion

By Chiara S.   Nobile M.T.   Barzacchi C.   Sanguineti O.   Vincenti M.   Di Somma C.   Meszaros P.   Rosso R.  

European Journal of Cancer, Vol. 33, Iss. 6, 1997-05 ,pp. : 967-969

Elsevier

Access to resources Recommend Favorite

Could the hand-foot syndrome after capecitabine treatment be associated with better outcome in metastatic breast cancer patients?

By Kurt Mevlut   Aksoy Sercan   Guler Nilufer  

Acta Oncologica, Vol. 45, Iss. 5, 2006-07 ,pp. : 625-626

Informa Healthcare

Access to resources Recommend Favorite

Hand-foot syndrome in a patient with metastatic lung adenocarcinoma induced by high-dose icotinib: A case report and review of the literature

By Zheng Yulong   Fang Weijia   Xu Nong  

Oncology Letters, Vol. 4, Iss. 6, 2012-12 ,pp. : 1341-1343

Spandidos Publications

Access to resources Recommend Favorite